Cargando…

Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer

BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopont...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yin-Hsun, Su, Yu-Chu, Lin, Shuo-Fu, Lin, Pey-Ru, Wu, Chao-Liang, Tung, Chao-Ling, Li, Chien-Feng, Shieh, Gia-Shing, Shiau, Ai-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688208/
https://www.ncbi.nlm.nih.gov/pubmed/31399076
http://dx.doi.org/10.1186/s12885-019-6014-5
_version_ 1783442838123446272
author Feng, Yin-Hsun
Su, Yu-Chu
Lin, Shuo-Fu
Lin, Pey-Ru
Wu, Chao-Liang
Tung, Chao-Ling
Li, Chien-Feng
Shieh, Gia-Shing
Shiau, Ai-Li
author_facet Feng, Yin-Hsun
Su, Yu-Chu
Lin, Shuo-Fu
Lin, Pey-Ru
Wu, Chao-Liang
Tung, Chao-Ling
Li, Chien-Feng
Shieh, Gia-Shing
Shiau, Ai-Li
author_sort Feng, Yin-Hsun
collection PubMed
description BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopontin (OPN) and Oct4 expression in human lung cancer was determined by performing immunohistochemistry. Immunoblotting, ELISA, luciferase reporter assay, chromatin immunoprecipitation assay and RT-PCR were performed to validate the regulation of Oct4-Egr1-OPN axis. Moreover, the effect of Oct4-Egr1-OPN axis on lung cancer progression was evaluated by cell migration assay and mice study. RESULTS: We detected Oct4, Egr1, and OPN expression in clinical specimens from 79 lung cancer patients, including 72 adenocarcinomas and 7 squamous cell carcinomas. High expression of Oct4, Egr1, and OPN accounted for 53, 51, and 57% of the patients, respectively. All of the three biomarkers were positively correlated in clinical human lung cancer. Patients with high expression of OPN were significantly associated with shorter disease-free survivals than those with low expression of OPN (p < 0.05). In lung cancer cells, Oct4 transactivated the Egr1 promoter and upregulated Egr1 expression. In a human lung cancer xenograft model, Oct4-overexpressing tumors expressed elevated levels of Egr1. Furthermore, overexpression of Oct4 in lung cancer cells increased the metastatic potential. CONCLUSIONS: Egr1 exerts a promoting effect on cancer metastasis in Oct4-overexpressing lung cancer. Thus, therapeutic strategies targeting the Oct4/Egr1/OPN axis may be further explored for the treatment of lung cancer, especially when lung cancer is refractory to conventional treatment due to cancer stem cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-6014-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6688208
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66882082019-08-14 Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer Feng, Yin-Hsun Su, Yu-Chu Lin, Shuo-Fu Lin, Pey-Ru Wu, Chao-Liang Tung, Chao-Ling Li, Chien-Feng Shieh, Gia-Shing Shiau, Ai-Li BMC Cancer Research Article BACKGROUND: Roles of cancer stem cells and early growth response gene 1 (Egr1) in carcinogenesis have been extensively studied in lung cancer. However, the role of Egr1 in the metastasis of lung cancer remains undetermined, especially in regard to stem cell-related pathways. METHODS: Egr1, osteopontin (OPN) and Oct4 expression in human lung cancer was determined by performing immunohistochemistry. Immunoblotting, ELISA, luciferase reporter assay, chromatin immunoprecipitation assay and RT-PCR were performed to validate the regulation of Oct4-Egr1-OPN axis. Moreover, the effect of Oct4-Egr1-OPN axis on lung cancer progression was evaluated by cell migration assay and mice study. RESULTS: We detected Oct4, Egr1, and OPN expression in clinical specimens from 79 lung cancer patients, including 72 adenocarcinomas and 7 squamous cell carcinomas. High expression of Oct4, Egr1, and OPN accounted for 53, 51, and 57% of the patients, respectively. All of the three biomarkers were positively correlated in clinical human lung cancer. Patients with high expression of OPN were significantly associated with shorter disease-free survivals than those with low expression of OPN (p < 0.05). In lung cancer cells, Oct4 transactivated the Egr1 promoter and upregulated Egr1 expression. In a human lung cancer xenograft model, Oct4-overexpressing tumors expressed elevated levels of Egr1. Furthermore, overexpression of Oct4 in lung cancer cells increased the metastatic potential. CONCLUSIONS: Egr1 exerts a promoting effect on cancer metastasis in Oct4-overexpressing lung cancer. Thus, therapeutic strategies targeting the Oct4/Egr1/OPN axis may be further explored for the treatment of lung cancer, especially when lung cancer is refractory to conventional treatment due to cancer stem cells. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-019-6014-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-09 /pmc/articles/PMC6688208/ /pubmed/31399076 http://dx.doi.org/10.1186/s12885-019-6014-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Feng, Yin-Hsun
Su, Yu-Chu
Lin, Shuo-Fu
Lin, Pey-Ru
Wu, Chao-Liang
Tung, Chao-Ling
Li, Chien-Feng
Shieh, Gia-Shing
Shiau, Ai-Li
Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
title Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
title_full Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
title_fullStr Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
title_full_unstemmed Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
title_short Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer
title_sort oct4 upregulates osteopontin via egr1 and is associated with poor outcome in human lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688208/
https://www.ncbi.nlm.nih.gov/pubmed/31399076
http://dx.doi.org/10.1186/s12885-019-6014-5
work_keys_str_mv AT fengyinhsun oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT suyuchu oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT linshuofu oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT linpeyru oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT wuchaoliang oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT tungchaoling oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT lichienfeng oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT shiehgiashing oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer
AT shiauaili oct4upregulatesosteopontinviaegr1andisassociatedwithpooroutcomeinhumanlungcancer